Synthesis, conformational analysis, and biological evaluation of 19-nor-vitamin D3 analogues with A-ring modifications

Journal of Medicinal Chemistry

Volumn 52, Issue 19, 2009, Pages 6158-6162

  Sánchez Abella, Laura ^a   Fernández, Susana ^a   Verstuyf, Annemieke ^b   Verlinden, Lieve ^b   Gotor, Vicente ^a   Ferrero, Miguel ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

19 NOR VITAMIN D3; 1ALPHA,2ALPHA,25 TRIHYDROXY 19 NOR VITAMIN D3; 2BETA,3BETA EPOXY 1ALPHA,25 DIHYDROXY 3 DEOXY 19 NOR VITAMIN D3; ANTINEOPLASTIC AGENT; COLECALCIFEROL; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL; CONFORMATIONAL TRANSITION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLECALCIFEROL; FEMALE; HUMANS; MOLECULAR CONFORMATION; RECEPTORS, CALCITRIOL; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 70349645983     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm900711d     Document Type: Article

References (16)

1. (a) Eelen, G.; Gysemans, C.; Verlinden, L.; Vanoirbeek, E.; De Clercq, P.; Van Haver, D.; Mathieu, C.; Bouillon, R.; Verstuyf, A. Mechanism and potential of the growth-inhibitory actions of vitamin D and analogs. Curr. Med. Chem. 2007, 14, 1893-1910.
2. (b) Agoston, E. S.; Hatcher, M. A.; Kensler, T. W.; Posner, G. H. Vitamin D analogs as anti-carcinogenic agents. Anticancer Agents Med. Chem. 2006, 6, 53-71.
3. Perlman, K. L.; Swenson, R. E.; Paaren, H. E.; Schnoes, H. K.; DeLuca, H. F. Novel synthesis of 19-nor-vitamin D compounds. Tetrahedron Lett. 1991, 32, 7663-7666.
4. 3 with a trans-Fused Decalin CD-Ring has Pronounced Genomic Activity. J. Biol. Chem. 2003, 278, 35476-35482.
5. 3. J. Bone Miner. Res. 1993, 8, 1009-1015.
6. 3 Analogues of High Intestinal Activity: Synthesis and Biological Evaluation of 2-(3′-Alkoxypropylidene) and 2-(3′-Hydroxypropylidene) Derivatives. J. Med. Chem. 2006, 49, 2909-2920.
7. 3 analogs: synthesis, biological evaluation, and crystal structure. Bioorg. Med. Chem. 2008, 16, 6949-6964.
8. 3. J. Med. Chem. 1994, 37, 3730-3738.
9. (b) Shimizu, M.; Iwasaki, Y.; Shinamoto, Y.; Sato, M.; DeLuca, H. F.; Yamada, S. Novel synthesis of 2-Substituted 19-norvitamin D A-ring phosphine oxide from D-glucose as a building block. Bioorg. Med. Chem. Lett. 2003, 13, 809-812.
10. 3 with Julia olefination: high potency in induction of differentiation on HL-60 cells. J. Org. Chem. 2003, 68, 7407-7415.
11. 3 analogues. Bioorg. Med. Chem. 2007, 15, 4193-4202.
12. (a) Armesto, N.; Ferrero, M.; Fernández, S.; Gotor, V. Efficient synthesis of (-)-methyl 3-epi-shikimate and methyl 3-epi-quinate by one-pot selective protection of trans-1,2-diols. Tetrahedron Lett. 2000, 41, 8759-8762. (Pubitemid 30834831)
13. (b) Fernández, S.; Díaz, M.; Ferrero, M.; Gotor, V. New and efficient enantiospecific synthesis of (-)-methyl 5-epishikimate and methyl 5-epi-quinate from (-)-quinic acid. Tetrahedron Lett. 1997, 38, 5225-5228. (Pubitemid 27294655)
14. 3. Steroids 1995, 60, 324-332.
15. Sánchez-Abella, L.; Fernández, S.; Armesto, N.; Ferrero, M.; Gotor, V. Novel and Efficient Syntheses of (-)-Methyl 4-epi- Shikimate and 4,5-Epoxy-Quinic and -Shikimic Acid Derivatives as Key Precursors to Prepare New Analogues. J. Org. Chem. 2006, 71, 5396-5399.
16. 3 analogues with A-ring modifications. Bioorg. Med. Chem. 2008, 16, 10244-10250.